caseintelcaseintel
← Back to Dashboard
Litigation Stage Tracker
Active Filing

Roundup / Monsanto

OpenFILING
MDL 2741Chemical
4,200+
Total Cases

Causation

IARC classified glyphosate as 'probably carcinogenic to humans' (Group 2A) in 2015. Plaintiffs' experts rely on epidemiological studies showing 41% increased NHL risk among heavy glyphosate users, animal carcinogenicity data, and genotoxicity/oxidative stress mechanisms. Internal Monsanto documents (the 'Monsanto Papers') revealed ghostwriting of favorable studies and efforts to suppress unfavorable research. Three California juries found causation proved by preponderance of the evidence.

Defendants

EntityRoleNote
Bayer AGParent CompanyAcquired Monsanto in 2018 for $63B — inherited all Roundup liabilities
Monsanto CompanyOriginal ManufacturerDeveloped and marketed Roundup; internal documents show knowledge of cancer risk
BASF SECo-Formulant SupplierSupplied surfactants used in Roundup formulations — limited exposure

Litigation Timeline

Aug 2018
Johnson v. Monsanto — $289M verdict (first trial, reduced to $78M)
Mar 2019
Hardeman v. Monsanto — $80M federal bellwether verdict
May 2019
Pilliod v. Monsanto — $2B verdict (reduced to $87M)
Jun 2020
Bayer announces $10.9B settlement for ~100,000 claims
Jun 2025
Supreme Court denies cert on Bayer preemption challenge
2026
4,200+ cases remain pending; settlement processing continues

Intelligence Signals

Courtcourt
Schramm v. Monsanto Company
Courtcourt
Hooper v. Monsanto Company
Courtcourt
Kay v. Monsanto Company
Courtcourt
Tudal v. Monsanto Company
Courtcourt
Dunn v. Monsanto Company

Key Facts

Status
active

Geographic Exposure

·N.D. Cal. (MDL 2741, Judge Chhabria)
·California state courts (major verdict jurisdiction)
·Missouri (St. Louis — significant filings)
·Nationwide — all 50 states

Eligibility Criteria

  • Used Roundup or glyphosate-based herbicides regularly
  • Diagnosed with non-Hodgkin lymphoma (any subtype)
  • Exposure occurred before NHL diagnosis
  • Agricultural workers, landscapers, and residential users with significant use history